KRAS and neoplasm: Supplemental Table 2 summarises data reported in the original publications of these trials, where only 2 of the 8 included studies demonstrated statistically significant improvement in overall survival in the patients with KRAS WT tumours and none reported benefit in the patients with KRAS MT tumours.